National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 360163

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

VAERS ID: 360163
Age:15.0
Gender:Female
Location:Illinois
Vaccinated:2009-02-13
Onset:2009-03-03
Submitted:2009-10-08
Entered:2009-10-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0650X / 2 LA / IM

Administered by: Private      Purchased by: Other
Symptoms: Antinuclear antibody negative, Blood glucose increased, Blood thyroid stimulating hormone normal, Blood urea increased, C-reactive protein increased, Haemoglobin decreased, Joint swelling, Lymphocyte count decreased, Monocyte count increased, Neutrophil count increased, Oedema peripheral, Pain in extremity, Rheumatoid arthritis, Rheumatoid factor positive, Tenderness, Ultrasound Doppler normal, White blood cell count increased, X-ray normal, Red blood cell sedimentation rate increased, Musculoskeletal stiffness, Rheumatoid factor increased, Parvovirus B19 serology negative, Anti-cyclic citrullinated peptide antibody positive

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: SYNTHROID
Current Illness: Hypothyroidism; Eczema; Acne
Preexisting Conditions: Adverse drug reaction. 10/19/09 Primary Care Records and Rheumatology consult received for dates of service 2/14/00-9/18/09. PMH: Eczema, hypothyroidism, acne, tonsillectomy, fracture of R radius, NKDA.
Diagnostic Lab Data: serum rheumatoid factor, 08/18/09, 347 IU/m, erythrocyte, 08/18/09, 41 mm/h; erythrocyte, 06/09/09, 17 mm/h; serum ANA, 06/09/09, negative; serum rheumatoid factor, 06/09/09. 38 IU/M; serum C-reactive, 06/09/09, 1.06 mg/d; serum cyclic citr
CDC 'Split Type': WAES0909USA01491

Write-up:Information has been received from a medical assistant concerning a 16 year old female with hypothyroidism, eczema and acne who on 06-JUN-2008 was vaccinated with the first dose of GARDASIL (0.5ml, IM). The patient received the second dose of GARDASIL (0.5ml, IM) on unspecified date. On 13-FEB-2009 the patient received the third dose of GARDASIL (0.5ml, IM). The patient was diagnosed with viral or early rheumatoid arthritis by a rheumatologist. Her symptoms began 1 month after the third vaccination. The rheumatologist evaluated the patient in May 2009 where he said it was either viral arthritis or early rheumatoid arthritis. The rheumatologist said the patient was not in acute distress but joints were sensitive. The rheumatologist said he was leaning to early rheumatoid arthritis because of the duration of symptoms. At the reporting time the patient had not recovered. Follow-up information has been received from a clinical manager: The patient had previous drug reaction (vomiting) to codeine and CEFTIN. The patient was vaccinated with GARDASIL series as following: the first dose on 06-JUN-2008, lot# 658558/1061U; the second dose on 28-JUL-2008, lot# 658558/1061U; the third dose on 13-FEB-2009, lot# 661764/0650X; no other vaccines given on these dates. Concomitant therapy included SYNTHROID. The consult report from a rheumatologist from May 2009 showed "early rheumatoid arthritis". The report from the rheumatologist from 25-AUG-2009 showed that the patient was started on ENBREL, 50 mg weekly and methotrexate, 12.5 mg weekly for rheumatoid arthritis (RA). Follow-up information was received from the medical assistant via medical records indicating that the patient was a student and was vaccinated with three doses of GARDASIL IM in the left arm. The patient''s symptoms occurred on 03-MAR-2009. On 02-MAY-2009 parvovirus B-19 antibody (IGM) was negative (<0.9), rheumatoid factor was 21 IU/ml, C-reactive protein was 0.26 mg/dl, thyroid-stimulating hormone (TSH) was 3.36 mIU/L and sed rate was 11 mm/h. She was diagnosed w


Changed on 6/14/2014

VAERS ID: 360163 Before After
Age:15.0
Gender:Female
Location:Illinois
Vaccinated:2009-02-13
Onset:2009-03-03
Submitted:2009-10-08
Entered:2009-10-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0650X / 2 LA / IM

Administered by: Private      Purchased by: Other
Symptoms: Antinuclear antibody negative, Blood glucose increased, Blood thyroid stimulating hormone normal, Blood urea increased, C-reactive protein increased, Haemoglobin decreased, Joint swelling, Lymphocyte count decreased, Monocyte count increased, Neutrophil count increased, Oedema peripheral, Pain in extremity, Rheumatoid arthritis, Rheumatoid factor positive, Tenderness, Ultrasound Doppler normal, White blood cell count increased, X-ray normal, Red blood cell sedimentation rate increased, Musculoskeletal stiffness, Rheumatoid factor increased, Parvovirus B19 serology negative, Anti-cyclic citrullinated peptide antibody positive

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: SYNTHROID
Current Illness: Hypothyroidism; Eczema; Acne
Preexisting Conditions: Adverse drug reaction. 10/19/09 Primary Care Records and Rheumatology consult received for dates of service 2/14/00-9/18/09. PMH: Eczema, hypothyroidism, acne, tonsillectomy, fracture of R radius, NKDA.
Diagnostic Lab Data: serum rheumatoid factor, 08/18/09, 347 IU/m, erythrocyte, 08/18/09, 41 mm/h; erythrocyte, 06/09/09, 17 mm/h; serum ANA, 06/09/09, negative; serum rheumatoid factor, 06/09/09. 38 IU/M; serum C-reactive, 06/09/09, 1.06 mg/d; serum cyclic citr
CDC 'Split Type': WAES0909USA01491

Write-up:Information has been received from a medical assistant concerning a 16 year old female with hypothyroidism, eczema and acne who on 06-JUN-2008 was vaccinated with the first dose of GARDASIL (0.5ml, IM). The patient received the second dose of GARDASIL (0.5ml, IM) on unspecified date. On 13-FEB-2009 the patient received the third dose of GARDASIL (0.5ml, IM). The patient was diagnosed with viral or early rheumatoid arthritis by a rheumatologist. Her symptoms began 1 month after the third vaccination. The rheumatologist evaluated the patient in May 2009 where he said it was either viral arthritis or early rheumatoid arthritis. The rheumatologist said the patient was not in acute distress but joints were sensitive. The rheumatologist said he was leaning to early rheumatoid arthritis because of the duration of symptoms. At the reporting time the patient had not recovered. Follow-up information has been received from a clinical manager: The patient had previous drug reaction (vomiting) to codeine and CEFTIN. The patient was vaccinated with GARDASIL series as following: the first dose on 06-JUN-2008, lot# 658558/1061U; the second dose on 28-JUL-2008, lot# 658558/1061U; the third dose on 13-FEB-2009, lot# 661764/0650X; no other vaccines given on these dates. Concomitant therapy included SYNTHROID. The consult report from a rheumatologist from May 2009 showed "early rheumatoid arthritis". The report from the rheumatologist from 25-AUG-2009 showed that the patient was started on ENBREL, 50 mg weekly and methotrexate, 12.5 mg weekly for rheumatoid arthritis (RA). Follow-up information was received from the medical assistant via medical records indicating that the patient was a student and was vaccinated with three doses of GARDASIL IM in the left arm. The patient''s symptoms occurred on 03-MAR-2009. On 02-MAY-2009 parvovirus B-19 antibody (IGM) was negative (<0.9), rheumatoid factor was 21 IU/ml, C-reactive protein was 0.26 mg/dl, thyroid-stimulating hormone (TSH) was 3.36 mIU/L and sed rate was 11 mm/h. She was diagnosed w


Changed on 2/14/2017

VAERS ID: 360163 Before After
Age:15.0
Gender:Female
Location:Illinois
Vaccinated:2009-02-13
Onset:2009-03-03
Submitted:2009-10-08
Entered:2009-10-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0650X / 2 LA / IM

Administered by: Private      Purchased by: Other
Symptoms: Antinuclear antibody negative, Blood glucose increased, Blood thyroid stimulating hormone normal, Blood urea increased, C-reactive protein increased, Haemoglobin decreased, Joint swelling, Lymphocyte count decreased, Monocyte count increased, Neutrophil count increased, Oedema peripheral, Pain in extremity, Rheumatoid arthritis, Rheumatoid factor positive, Tenderness, Ultrasound Doppler normal, White blood cell count increased, X-ray normal, Red blood cell sedimentation rate increased, Musculoskeletal stiffness, Rheumatoid factor increased, Parvovirus B19 serology negative, Anti-cyclic citrullinated peptide antibody positive

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: SYNTHROID
Current Illness: Hypothyroidism; Eczema; Acne
Preexisting Conditions: Adverse drug reaction. 10/19/09 Primary Care Records and Rheumatology consult received for dates of service 2/14/00-9/18/09. PMH: Eczema, hypothyroidism, acne, tonsillectomy, fracture of R radius, NKDA.
Diagnostic Lab Data: serum rheumatoid factor, 08/18/09, 347 IU/m, erythrocyte, 08/18/09, 41 mm/h; erythrocyte, 06/09/09, 17 mm/h; serum ANA, 06/09/09, negative; serum rheumatoid factor, 06/09/09. 38 IU/M; serum C-reactive, 06/09/09, 1.06 mg/d; serum cyclic citr citrulline, 06/09/09, 20 unit; erythrocyte, 05/02/09, 11 mm/h; serum rheumatoid factor, 05/02/09, 21 IU/m; serum C-reactive, 05/02/09, 0.26 mg/d; serum B19 virus IgM, 05/02/2009, <0.9; serum TSH, 05/02/09, 3.36 mIU/. 10/19/09 Primary Care Records and Rheumatology consult received for dates of service 2/14/00-9/18/09. Labs and diagnostics: Rheumatoid Factor 347 (H), Sed. rate 41 (H), C-Reactive protein-1.06 (H). BUN 22 (H), Glucose 100 (H), WBC 16.7 (H), Hgb 11.0 (L), Neutorphil 76.2% (H), Lymphocyte 17.5%
CDC 'Split Type': WAES0909USA01491

Write-up:Information has been received from a medical assistant concerning a 16 year old female with hypothyroidism, eczema and acne who on 06-JUN-2008 was vaccinated with the first dose of GARDASIL (0.5ml, IM). The patient received the second dose of GARDASIL (0.5ml, IM) on unspecified date. On 13-FEB-2009 the patient received the third dose of GARDASIL (0.5ml, IM). The patient was diagnosed with viral or early rheumatoid arthritis by a rheumatologist. Her symptoms began 1 month after the third vaccination. The rheumatologist evaluated the patient in May 2009 where he said it was either viral arthritis or early rheumatoid arthritis. The rheumatologist said the patient was not in acute distress but joints were sensitive. The rheumatologist said he was leaning to early rheumatoid arthritis because of the duration of symptoms. At the reporting time the patient had not recovered. Follow-up information has been received from a clinical manager: The patient had previous drug reaction (vomiting) to codeine and CEFTIN. The patient was vaccinated with GARDASIL series as following: the first dose on 06-JUN-2008, lot# 658558/1061U; the second dose on 28-JUL-2008, lot# 658558/1061U; the third dose on 13-FEB-2009, lot# 661764/0650X; no other vaccines given on these dates. Concomitant therapy included SYNTHROID. The consult report from a rheumatologist from May 2009 showed "early rheumatoid arthritis". The report from the rheumatologist from 25-AUG-2009 showed that the patient was started on ENBREL, 50 mg weekly and methotrexate, 12.5 mg weekly for rheumatoid arthritis (RA). Follow-up information was received from the medical assistant via medical records indicating that the patient was a student and was vaccinated with three doses of GARDASIL IM in the left arm. The patient''s symptoms occurred on 03-MAR-2009. On 02-MAY-2009 parvovirus B-19 antibody (IGM) was negative (<0.9), rheumatoid factor was 21 IU/ml, C-reactive protein was 0.26 mg/dl, thyroid-stimulating hormone (TSH) was 3.36 mIU/L and sed rate was 11 mm/h. She was diagnosed w with rheumatoid arthritis at the end of May 2009. On 09-JUN-2009 rheumatoid factor was 38 IU/ml, C-reactive protein was 1.06 mg/dl, cyclic citrullinated peptide IgG antibody was 20 unites, sed rate was 17 mm/h and antinuclear antibodies was negative. On 18-AUG-2009 rheumatoid factor was 347 IU/ml and sed rate was 41 mm/h. At the time of reporting, the patient had not recovered from rheumatoid arthritis. The reporter considered rheumatoid arthritis to be disabling. Additional information is not expected. All available medical records will be provided upon request. 10/19/09 Primary Care Records and Rheumatology consult received for dates of service 2/14/00-9/18/09 Dx: Rheumatoid Arthritis Assessment: Per rheumatologist: Pt. c/o pain in feet and hands and wrists since 8/08. Her fingers have started to swell and she has significant morning stiffness. For several weeks she has been stiff when she wakes up and it is difficult to get out of bed, with the stiffness lasting several hours. There is no family history of arthritis. On exam she has multiple tender small joints in her hands. Her MCP and PIP joints are swollen. There is tenderness in the wrists. She is tender over the metatarsal area of the feet and the area has trace swelling. There is a possibility of another autoimmune disease such as lupus or other inflammatory arthritis. Medrol Dosepak prescribed with plan to switch to Naprosyn BID. Also started on Methotrexate weekly, sulfasalazine and folic acid. Later switched to Enbrel weekly.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=360163&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166